var ajaxurl = "http://capricor.com/mobile/wp-admin/admin-ajax.php/wp-admin/admin-ajax.php"; var cf_name = "Your Name"; var cf_email = "Your Email"; var cf_phone = "Your Phone..."; var cf_website = "Your Website"; function getInternetExplorerVersion() { var rv = -1; // Return value assumes failure. if (navigator.appName == 'Microsoft Internet Explorer') { var ua = navigator.userAgent; var re = new RegExp("MSIE ([0-9]{1,}[\.0-9]{0,})"); if (re.exec(ua) != null) rv = parseFloat( RegExp.$1 ); } return rv; } function checkVersion() { var msg = "You're not using Internet Explorer."; var ver = getInternetExplorerVersion(); if ( ver > -1 ) { if ( ver <= 8.0 ) return true; } return false; }

Corporate Overview

Capricor Therapeutics, Inc. is a heart failure biotechnology company focused on the development of novel therapeutics to prevent and treat heart disease.  Our company is strategically positioned at the forefront of one of the highest demand fields within medicine today: heart failure, a condition that costs the U.S. healthcare system nearly $40 billion annually.

Capricor Therapeutics has two unique and transformative heart failure technologies.  Our allogeneic cardiac-derived cells (CDCs) are aimed at attenuating and potentially improving damage to the heart that can result in heart failure. Our lead CDC drug candidate is CAP-1002. Our novel peptide, Cenderitide, is intended to treat patients following hospital discharge from an acute episode of heart failure.  Both CDCs and Cenderitide have shown positive results in Phase I studies. The safety and efficacy of CAP-1002 is being currently evaluated in the ALLSTAR Phase I/II trial, while the design and timing for a Cenderitide Phase I/II is being evaluated.

May 15, 2014 -  Capricor Therapeutics First Quarter 2014 Business Update Conference Call
Download Accompanying Slide Presentation

March 26, 2014 -  Capricor Therapeutics Investor Presentation at the ARM Regen Med Investor Day

March 26, 2014 -  A live webcast of all ARM Regen Med Investor Day panels and company presentations, including Dr. Marbán’s presentation at 1:45-2:00 p.m. ET

March 10, 2014 - Capricor Therapeutics Investor Presentation at the ROTH Conference

March 10, 2014 - Webcast of Dr. Marbán’s presentation at the ROTH Conference